Parthenolide reduces MCL-1 levels while increasing MAIP-1 levels in non-small cell lung cancer (NSCLC) cells, causing ER stress and inducing cell cycle arrest and apoptosis. Here, MAIP1 is linked to non-small cell lung carcinoma.